NEW YORK (GenomeWeb) – GenMark Diagnostics and Nanosphere, two firms that sell molecular diagnostics platforms based on multiplexing technologies, recently provided updates on plans to expand their respective test menus and to develop next-generation instruments.

GenMark Diagnostics is inching closer to commercializing its automated, sample-to-answer NexGen system, and anticipates a small number of placements in Europe later this year ahead of a planned 2015 product launch in the US.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.